Article
High parathyroid hormone concentration in tenofovir-treated patients are due to inhibition of calcium-sensing receptor activity.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Jan 2018
Mingione Alessandra, Maruca Katia, Chiappori Federica, Pivari Francesca, Brasacchio Caterina, Quirino Tiziana, Merelli Ivan, Soldati Laura, Bonfanti Paolo, Mora Stefano
Abstract excerpt
Bone health impairment is a common finding in HIV-infected patients on antiretroviral treatment. High serum parathyroid hormone (PTH) concentration in patients on antiretroviral treatment containing tenofovir disoproxil fumarate (TDF) has been reported. Hyperparathyroidism was not always sustained by a reduction in vitamin D concentration. We thus hypothesized a direct inhibitory effect of TDF on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
